Challenge Yourself and Impact the Future! Element Solutions Inc (NYSE:ESI) is a leading specialty chemicals company whose operating businesses formulate a broad range of solutions that enhance the performance of products people use every day. Developed
Do you enjoy leading a team that provides a high-quality of service to customers? Are you a Project Management Leader looking for a new opportunity? Join our Baker Hughes Valves Team! We devise smarter systems to
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
Job Description: Business Overview Rakuten Group provides more than 70 services in a wide range of fields, including e-commerce, travel, digital content, and other Internet services in Japan and overseas, as well as financial services such
Discover your future at Citi / シティでキャリアを築く Working at Citi is far more than just a job. A career with us means joining a team of more than 230,000 dedicated people from around the globe. At
Discover your future at Citi / シティでキャリアを築く Working at Citi is far more than just a job. A career with us means joining a team of more than 230,000 dedicated people from around the globe. At
Job Description: Department Overview Rakuten Travel’s global business is expanding travel-related services for overseas markets, partners, and customers. Rakuten Travel Xchange Business Office and Global Travel Management Department work with business, marketing, product, customer support, administrative
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Description: Department Overview The Global Travel Management Department of Rakuten Travel is accelerating Rakuten Travels global business expansion, particularly services for international users traveling to Japan and future global business development. Through travel services centered
Company Description At Western Digital, our vision is to power global innovation and push the boundaries of technology to make what you thought was once impossible, possible. At our core, Western Digital is a company of
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Brief Description Seeking an experienced Senior Project Manager to lead delivery across three concurrent, equal-priority GxP safety-system technology initiatives: the Oracle Argus upgrade, the RxLogix PV Intake upgrade, and the Safety Database Japan Enablement / Implementation.
General Information Job Advert Title: Senior Scientist, Applied Safety JP, Applied Safety Location: Tsukuba, Ibaraki Division: Early Development and Translational Science Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)